AzTrials
AzTrials

Coronary Artery Bypass GraftingNCT06956911

Effect of Early Low Resisted Exercise With Blood Flow Restriction on Pulmonary Function in Post Cardiac Surgery Patient

A study testing traditional cardiac rehabilitation with early low resisted exercise with blood flow restriction and traditional cardiac rehabilitation in people with Coronary Artery Bypass Grafting and Post Coronary Artery Bypass Grafting, run by Cairo University at 1 site in Egypt.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

After cardiac surgery Patients present a loss of exercise capacity, muscle mass, and quality of life Cardiopulmonary rehabilitation aims to reduce the loss of muscle strength, size and increase cardiopulmonary function so that quality of life is maintained as much as possible after open-heart surgeries. Read more about this study

Who is it for?
Ages 45 to 60 years, men only
What is being tested?
traditional cardiac rehabilitation with early low resisted exercise with blood flow restriction and traditional cardiac rehabilitation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteEgypt
Study dates
7 Nov 2024to 15 Jun 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 60 years
  • Men only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Male patient aged from 45-60
  • Elective open heart surgery via median sternotomy
  • Post operative, extubated post open heart surgery, who can follow the instructions and sign the consent form
  • Hemodynamic stability
  • Neurological stability

Who cannot join

  • Still on mechanical ventilation more than 48 hours
  • Neuromuscular diseases
  • Rheumatoid arthritis
  • Coagulopathy
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cardiac arrhythmias

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Egypt1 site
  • National heart institute

    Cairo, Cairo Governorate, 3753450

Other trials in Egypt

About this study

After cardiac surgery Patients present a loss of exercise capacity, muscle mass, and quality of life Cardiopulmonary rehabilitation aims to reduce the loss of muscle strength, size and increase cardiopulmonary function so that quality of life is maintained as much as possible after open-heart surgeries. Traditionally, cardiac rehabilitation consist of low-intensity aerobic exercise. Therefore, cardiac rehabilitation should include not only aerobic but also resistance training (RT),. A safe and effective version of RT is needed that can still improve muscle strength and size in patients early after cardiac surgery,It is found that BFR can achieve the same result with low intensity which is suitable for patient post cardiac surgery,so the result of this study will provide a safe resisted exercise useful for post cardiac surgery patient

Being tested
traditional cardiac rehabilitation with early low resisted exercise with blood flow restriction, traditional cardiac rehabilitation
Keywords
Post Coronary Artery Bypass Grafting

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • traditional cardiac rehabilitation with early low resisted exercise with blood flow restrictionDevice

    Traditional cardiac rehabilitation and early low resisted exercise with 0.5 kilogram in form of bilateral upper limb exercise (elbow flexion and extension,wrist flexion and extension ) with external pressure applied with pressure cuff which determined by 40% of systolic blood pressure which applied on the proximal part of the arm,the frequency of exercise is once per day for 14 consecutive day and intensity determined by rate of perceived exertion scale

  • traditional cardiac rehabilitationDevice

    Diaphragmatic and costal breathing exercise, active assisted to active range of motion,percussion,splinted cough,early mobility, upper limb exercise with breathing and incentive spirometer

Study groups in NCT06956911
Study groupRoleWhat they receive
study groupExperimentalTraditional cardiac rehabilitation with early low resisted exercise with blood flow restriction
Receives: Device: traditional cardiac rehabilitation with early low resisted exercise with blood flow restriction
control groupActive comparatorTraditional cardiac rehabilitation only
Receives: Device: traditional cardiac rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pulmonary function test, parameters that be measured is FVC and will be expressed as % of the predicted value for age,height,weight and sex and FEV1 and will be expressed as % of the predicted value of age ,sex,weight and height

    parameters that be measured is FVC and will be expressed as % of the predicted value for age, height ,weight and sex and FEV1 and will be expressed as % of the predicted value of age ,sex, weight and height

    Measured: fourteen days

  2. Hand grip strength

    measure hand grip strength by hand held dynamometer (digital apperatus) expressed by kilogram

    Measured: fourteen days

  3. c-reactive protein lab

    Measured: fourteen days

  4. Functional capacity

    measure functional capacity by six minute walk test by calculate the total distance covered by the patient expressed by meters

    Measured: fourteen days ,first measure will be at the session of assessment and last measure will be at the end of treatment program after fourteen days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 May 2025
  2. Study start7 Nov 2024
  3. Primary completion20 Mar 2025
  4. Study completion15 Jun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06956911
Sponsor's protocol ID
P.T.REC\012\005679
Status last verified
Apr 2025
First submitted
16 Apr 2025
Last updated
4 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing traditional cardiac rehabilitation with early low resisted exercise with blood flow restriction and traditional cardiac rehabilitation in people with Coronary Artery Bypass Grafting and Post Coronary Artery Bypass Grafting, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 4 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pulmonary function test, parameters that be measured is FVC and will be expressed as % of the predicted value for age,height,weight and sex and FEV1 and will be expressed as % of the predicted value of age ,sex,weight and height (time frame: fourteen days). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in